Myeloma – upfront and RRMM
CLL – heading for a cure?
MPN update – focus on MF
High risk and resistant CML: new diagnostic tools and treatment approaches
Workshop: AML

ECHELON 1 : Brentuximab should be used first line in advanced Hodgkin lymphoma
GALLIUM : Obinutuzumab, not rituximab, should be used first line for patients with symptomatic follicular lymphoma

Confirmed Speakers:

  • Professor Tim Illidge (Christie Hospital, Manchester)
  • Professor Graham Jackson (NCCC, Newcastle)
  • Dr Andrew McMillan (Nottingham City Hospital)
  • Dr Wendy Osborne (Freeman Hospital, Newcastle)
  • Dr Steve Knapper (University Hospital, Wales)
  • Dr Mike Dennis (Christie Hospital, Manchester)
  • Professor Claire Harrison (Guy’s and St Thomas’ Hospital, London)
  • Dr Hugues de Lavallade (King’s College Hospital, London)